Primary Psychoses Among Sentenced Prisoners in Finland. [PDF]
Laivonen P, Laajasalo T, Rautanen M.
europepmc +1 more source
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Polygenic risk factors for comorbid diagnoses in individuals with substance use disorders: A phenome-wide survival analysis. [PDF]
Barr PB +6 more
europepmc +1 more source
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos +9 more
wiley +1 more source
Substance Use in Adolescents with ADHD and Bipolar Spectrum Disorders: The Transdiagnostic Role of Emotional Dysregulation, Impulsivity and Hypersensitivity Traits. [PDF]
Accorinti I +19 more
europepmc +1 more source
Structural Neuroimaging in Substance-Induced Psychosis. [PDF]
Atmaca M, Tabara MF.
europepmc +1 more source
Violence and threat exposure is associated with frontostriatal alterations during risky decision-making in children with co-morbid ADHD and disruptive behavior disorders. [PDF]
Aloi J +5 more
europepmc +1 more source
Stigma toward individuals with cannabis use disorder across age groups: associations with familiarity and sociodemographic characteristics. [PDF]
Basedow LA +4 more
europepmc +1 more source
Familial risk factors required to predict earlier adolescent substance use in youth with externalizing disorders. [PDF]
Smoker MP +8 more
europepmc +1 more source

